The endocannabinoid system interacts with gut peptide signaling (ghrelin, CCK, GLP-1) to modulate appetite through gut-brain communication, explaining why cannabis causes munchies and informing obesity drug targets.
Key findingThe endocannabinoid system modulates appetite through gut-brain signaling interactions with CCK, GLP-1, ghrelin, and leptin, regulating food intake vi
What the researchers found
The endocannabinoid system modulates appetite through gut-brain signaling interactions with CCK, GLP-1, ghrelin, and leptin, regulating food intake via vagal afferents and hypothalamic circuits — explaining cannabis appetite effects and informing cannabinoid-gut peptide drug combinations.
Why it matters
Relevant for neuropeptides, gut-healing, weight-loss.
How the study worked
review study.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2007.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
The endocannabinoid system and gut-brain signalling.
Current opinion in pharmacology, 7(6), 575-82
Citation
Storr, Martin A; Sharkey, Keith A. (2007). The endocannabinoid system and gut-brain signalling.. Current opinion in pharmacology, 7(6), 575-82.